ArticleMedicine2015

Use of a Novel Integrase-Deficient Lentivirus for Targeted Anti-Cancer Therapy With Survivin Promoter-Driven Diphtheria Toxin A.

Baoshun Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.